A major US study suggests that GLP-1 weight-loss drugs, already used widely for diabetes and obesity, may also be linked to reduced addiction risks and fewer drug-related harms, including overdose and death. Researchers say the medications could be dampening the brain’s craving systems. Here’s what you need to know.